The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583
Article in ERJ Open Research (January 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Cathepsin C regulates tumor progression via the Yes-associated protein signaling pathway in non-small cell lung cancer.
Article in American Journal of Cancer Research (January 2024)
Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease
Article in Frontiers in Immunology (December 2023)